BCAL Stock Analysis: California BanCorp | NASDAQ
Banks - Regional | NASDAQ, USA | Market Cap: 700m USD | 12M Return: 17.7% | US84252A1060 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 4.02M
EPS Trend: 74.2%
Qual. Beats: 0
Rev. Trend: 93.9%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.8 years of data, until 10/2026
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.
California BanCorp (NASDAQ: BCAL) is the bank holding company for California Bank of Commerce, N.A., a commercial bank headquartered in San Diego, California, founded in 2001. The company provides a full suite of banking products and services to individuals, professionals, and small- to medium-sized businesses across California. Its deposit offerings include checking, savings, money market accounts, and certificates of deposit, while its lending activities span business loans, commercial and industrial loans, SBA loans, consumer loans, and commercial real estate (CRE) loans, including multifamily residential, owner-occupied, and non-owner-occupied CRE financing. The bank also offers treasury management, merchant services, escrow and sub-accounting solutions, cash vault and remote deposit capture, online and mobile banking, and ACH origination and lockbox processing.
California BanCorp serves a diverse client base, including businesses, LLCs, partnerships, associations, governmental authorities, and organizations across multiple sectors such as manufacturing, wholesale distribution, professional services, commercial real estate, healthcare, hospitality, contracting, and non-profits. The company was formerly known as Southern California Bancorp and rebranded to California BanCorp in August 2024. As a community-oriented commercial bank, BCAL emphasizes relationship-based lending to local businesses, with a notable concentration in CRE loans-a loan category that typically carries higher yields but also higher risk sensitivity to interest rate cycles and local economic conditions in the California market.
- CRE concentration risk pressures credit quality and provisioning
- Net interest margin expansion fuels quarterly earnings growth
- SMB loan demand drives revenue and deposit expansion
| Net Income: 58.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA -0.20 > 1.0 |
| NWC/Revenue: -356.1% < 20% (prev -1.51k%; Δ 1.15k% < -1%) |
| CFO/TA 0.01 > 3% & CFO 52.3m > Net Income 58.5m |
| Net Debt (-307.3m) to EBITDA (84.5m): -3.64 < 3 |
| Current Ratio: 0.31 > 1.5 & < 3 |
| Outstanding Shares: last quarter (32.4m) vs 12m ago -1.30% < -2% |
| Gross Margin: 79.16% > 18% (prev 64.86%; Δ 14.30% > 0.5%) |
| Asset Turnover: 5.60% > 50% (prev 5.45%; Δ 0.15% > 0%) |
| Interest Coverage Ratio: 1.64 > 6 (EBIT TTM 79.8m / Interest Expense TTM 48.7m) |
| A: -0.20 (Total Current Assets 360.5m - Total Current Liabilities 1.18b) / Total Assets 4.11b |
| B: 0.04 (Retained Earnings 167.5m / Total Assets 4.11b) |
| C: 0.02 (EBIT TTM 79.8m / Avg Total Assets 4.10b) |
| D: 0.16 (Book Value of Equity 581.4m / Total Liabilities 3.52b) |
| Altman-Z'' = -0.87 = CCC |
As of November 20, 2026, the stock is trading at USD 21.14 with a total of 276,769 shares traded. Over the past week, the price has changed by -4.13%, over one month by -2.08%, over three months by +0.94% and over the past year by +17.65%.
Current recommended Stop Loss: 20.50 (which is 3% or 1.3 ATR below the current price).
California BanCorp has received a consensus analysts rating of 4.50. Therefore, it is recommended to buy BCAL.
- StrongBuy: 2
- Buy: 2
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 24.8 | 17.1% |
P/E Trailing = 12.1381
P/S = 3.8459
P/B = 1.2035
Revenue TTM = 229.7m USD
EBIT TTM = 79.8m USD
EBITDA TTM = 84.5m USD
Long Term Debt = 33.8m USD (from longTermDebt, last fiscal year)
Short Term Debt = unknown (none)
Debt = 53.2m USD (corrected: LT Debt 33.8m + ST Debt none) + Leases 19.4m
Net Debt = -307.3m USD (calculated: Debt 53.2m - CCE 360.5m)
Enterprise Value = 392.4m USD (699.7m + Debt 53.2m - CCE 360.5m)
Interest Coverage Ratio = 1.64 (Ebit TTM 79.8m / Interest Expense TTM 48.7m)
EV/FCF = 7.65x (Enterprise Value 392.4m / FCF TTM 51.3m)
FCF Yield = 13.07% (FCF TTM 51.3m / Enterprise Value 392.4m)
FCF Margin = 22.33% (FCF TTM 51.3m / Revenue TTM 229.7m)
Net Margin = 25.48% (Net Income TTM 58.5m / Revenue TTM 229.7m)
Gross Margin = 79.16% ((Revenue TTM 229.7m - Cost of Revenue TTM 47.9m) / Revenue TTM)
Gross Margin QoQ = 73.58% (prev 78.20%)
Tobins Q-Ratio = 0.10 (Enterprise Value 392.4m / Total Assets 4.11b)
Interest Expense / Debt = 91.56% (Interest Expense 48.7m / Debt 53.2m)
Taxrate = 26.61% (21.2m / 79.8m)
NOPAT = 58.5m (EBIT 79.8m * (1 - 26.61%))
Current Ratio = 0.31 (Total Current Assets 360.5m / Total Current Liabilities 1.18b)
Debt / Equity = 0.09 (Debt 53.2m / totalStockholderEquity, last quarter 581.4m)
Debt / EBITDA = -3.64 (Net Debt -307.3m / EBITDA 84.5m)
Debt / FCF = -5.99 (Net Debt -307.3m / FCF TTM 51.3m)
Total Stockholder Equity = 580.6m (last 4 quarters mean from totalStockholderEquity)
RoA = 1.43% (Net Income 58.5m / Total Assets 4.11b)
RoE = 10.08% (Net Income TTM 58.5m / Total Stockholder Equity 580.6m)
RoCE = 12.98% (EBIT 79.8m / Capital Employed (Equity 580.6m + L.T.Debt 33.8m))
RoIC = 2.01% (NOPAT 58.5m / Invested Capital 2.92b)
WACC = 7.16% (E(699.7m)/V(752.9m) * Re(7.70%) + (debt cost/tax rate unavailable))
Discount Rate = 7.70% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 65.06 | Cagr: 27.34%
[DCF] Terminal Value 73.28% ; FCFF base≈54.6m ; Y1≈48.4m ; Y5≈39.9m
[DCF] Fair Price = 29.70 (EV 638.5m - Net Debt -307.3m = Equity 945.7m / Shares 31.8m; r=8.35% [WACC [floored]]; 5y FCF grow -13.98% → 2.50% )
EPS Correlation: 74.24 | EPS CAGR: 26.58% | SUE: 0.0 | # QB: 0
Revenue Correlation: 93.93 | Revenue CAGR: 30.53% | SUE: 0.61 | # QB: 0
EPS current Quarter (2027-03-31): EPS=0.44 | Chg30d=+1.14% | Revisions=+25% | Analysts=4
EPS current Year (2026-12-31): EPS=1.75 | Chg30d=+0.14% | Revisions=+17% | GrowthEPS=-9.6% | GrowthRev=+1.4%
EPS next Year (2027-12-31): EPS=1.89 | Chg30d=+1.62% | Revisions=+17% | GrowthEPS=+8.2% | GrowthRev=+6.4%
[Analyst] Revisions Ratio: +30% (up=5, down=2)